UY33455A - Tableta con núcleo recubierto de liberación controlada - Google Patents
Tableta con núcleo recubierto de liberación controladaInfo
- Publication number
- UY33455A UY33455A UY0001033455A UY33455A UY33455A UY 33455 A UY33455 A UY 33455A UY 0001033455 A UY0001033455 A UY 0001033455A UY 33455 A UY33455 A UY 33455A UY 33455 A UY33455 A UY 33455A
- Authority
- UY
- Uruguay
- Prior art keywords
- cyano
- methyl
- inner core
- tablet
- thiazolecarboxylic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
La presente invención se refiere a una tableta de liberación controlada que contiene un núcleo interno y una porción de capa externa que cubre el núcleo interno, la cual puede mantener la concentración de ácido 2-(3-ciano-4-isobutiloxifenil)-4-metil-5-tiazolcarboxílico en la sangre a un cierto nivel o superior durante un largo período de tiempo, donde el núcleo interno contiene ácido 2-(3-ciano-4-isobutiloxifenil)-4-metil-5-tiazolcarboxílico, y la porción de capa externa contiene ácido 2-(3-ciano-4-isobutiloxifenil)-4-metil-5-tiazolcarboxílico y un polímero hidrosoluble formador de gel.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010137323 | 2010-06-16 | ||
JP2010137322 | 2010-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY33455A true UY33455A (es) | 2012-01-31 |
Family
ID=45348267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001033455A UY33455A (es) | 2010-06-16 | 2011-06-15 | Tableta con núcleo recubierto de liberación controlada |
Country Status (9)
Country | Link |
---|---|
US (1) | US8968779B2 (es) |
EP (1) | EP2594269A4 (es) |
JP (1) | JP5669837B2 (es) |
AR (1) | AR081935A1 (es) |
CA (1) | CA2802831C (es) |
MX (1) | MX339452B (es) |
TW (1) | TW201206502A (es) |
UY (1) | UY33455A (es) |
WO (1) | WO2011158870A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105579037A (zh) | 2013-05-31 | 2016-05-11 | 武田制药美国有限公司 | 用黄嘌呤氧化酶抑制剂治疗的方法和含黄嘌呤氧化酶抑制剂的组合物 |
JP2020525436A (ja) | 2017-06-21 | 2020-08-27 | ミネルバ・ニューロサイエンシズ・インコーポレイテッド | 胃耐性制御放出経口剤形 |
JP7377782B2 (ja) | 2019-09-04 | 2023-11-10 | 信越化学工業株式会社 | フィルム成形用組成物及びフィルム |
JP2021104974A (ja) * | 2019-12-26 | 2021-07-26 | 東和薬品株式会社 | フェブキソスタット製剤 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3720757A1 (de) | 1987-06-24 | 1989-01-05 | Bayer Ag | Dhp-manteltablette |
JP3220373B2 (ja) | 1995-11-28 | 2001-10-22 | バイエル薬品株式会社 | 持続性ニフエジピン製剤 |
UA74141C2 (uk) * | 1998-12-09 | 2005-11-15 | Дж.Д. Сірл Енд Ко. | Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти) |
US6136982A (en) | 1999-01-22 | 2000-10-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | Synthesis of 3-amino-2-chloro-4-methylpyridine from acetone and ethyl cyanoacetate |
AP1243A (en) | 1999-02-01 | 2004-02-02 | Servier Lab | Core tablet for controlled release of gliclazide after oral administration. |
EG23951A (en) | 1999-03-25 | 2008-01-29 | Otsuka Pharma Co Ltd | Cilostazol preparation |
JP4637338B2 (ja) | 2000-09-22 | 2011-02-23 | 大塚製薬株式会社 | シロスタゾール有核錠 |
JP4817562B2 (ja) * | 2001-09-26 | 2011-11-16 | 東和薬品株式会社 | 長時間持続型ニフエジピン有核錠 |
JP5105684B2 (ja) * | 2002-03-15 | 2012-12-26 | 大塚製薬株式会社 | 持続性医薬製剤 |
JP3751287B2 (ja) * | 2002-03-27 | 2006-03-01 | バイエル薬品株式会社 | 小型化されたニフェジピン有核錠剤 |
AU2003220909B2 (en) * | 2002-03-28 | 2008-09-18 | Teijin Limited | Solid preparation containing single crystal form |
AU2003301121A1 (en) * | 2002-12-18 | 2004-07-14 | Pain Therapeutics, Inc. | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
US9028867B2 (en) | 2005-08-18 | 2015-05-12 | Teijin Pharma Limited | Formulation having accurate dose-dividing function |
PE20070698A1 (es) * | 2005-11-14 | 2007-08-17 | Teijin Pharma Ltd | Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol |
SG184754A1 (en) | 2005-12-28 | 2012-10-30 | Takeda Pharmaceutical | Controlled release solid preparation |
US20100172988A1 (en) | 2006-01-10 | 2010-07-08 | Kissei Pharmaceutical Co., Ltd. | Sustained release preparation and method for production thereof |
NZ580972A (en) * | 2007-06-04 | 2012-02-24 | Egalet Ltd | Controlled release pharmaceutical compositions for prolonged effect |
JP5545952B2 (ja) | 2007-08-31 | 2014-07-09 | 第一三共株式会社 | 徐放性製剤及びその製造方法 |
US20100316711A1 (en) | 2007-10-25 | 2010-12-16 | Bayer Yakuhin ,Ltd. | Nifedipine containing opress coated tablet and method of preparing same |
JP5753082B2 (ja) * | 2009-06-26 | 2015-07-22 | 帝人ファーマ株式会社 | 高血圧症または正常高値血圧症の治療薬 |
CN101671315B (zh) * | 2009-08-19 | 2011-06-22 | 何广卫 | 非布索坦的新晶型及其制备方法 |
CN101658505A (zh) | 2009-09-29 | 2010-03-03 | 北京华禧联合科技发展有限公司 | 非布索坦的缓释制剂及其制备方法 |
PE20130574A1 (es) * | 2010-06-16 | 2013-06-01 | Takeda Pharmaceuticals Usa Inc | Nuevas formas de dosificacion de liberacion modificada de un inhibidor de la xantina oxidorreductasa o de inhibidores de xantina oxidasa |
-
2011
- 2011-06-15 AR ARP110102074A patent/AR081935A1/es unknown
- 2011-06-15 WO PCT/JP2011/063713 patent/WO2011158870A1/ja active Application Filing
- 2011-06-15 EP EP11795774.6A patent/EP2594269A4/en not_active Withdrawn
- 2011-06-15 TW TW100120881A patent/TW201206502A/zh unknown
- 2011-06-15 US US13/704,345 patent/US8968779B2/en not_active Expired - Fee Related
- 2011-06-15 CA CA2802831A patent/CA2802831C/en not_active Expired - Fee Related
- 2011-06-15 MX MX2012014437A patent/MX339452B/es active IP Right Grant
- 2011-06-15 JP JP2012520471A patent/JP5669837B2/ja not_active Expired - Fee Related
- 2011-06-15 UY UY0001033455A patent/UY33455A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2594269A1 (en) | 2013-05-22 |
US20130089609A1 (en) | 2013-04-11 |
WO2011158870A1 (ja) | 2011-12-22 |
TW201206502A (en) | 2012-02-16 |
MX339452B (es) | 2016-05-27 |
AR081935A1 (es) | 2012-10-31 |
JP5669837B2 (ja) | 2015-02-18 |
MX2012014437A (es) | 2013-02-26 |
JPWO2011158870A1 (ja) | 2013-08-19 |
CA2802831C (en) | 2018-11-20 |
CA2802831A1 (en) | 2011-12-22 |
EP2594269A4 (en) | 2013-12-04 |
US8968779B2 (en) | 2015-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2015003185A1 (es) | Aparato para la electroobtención o electrorefinación | |
BR112012000934A2 (pt) | cassetes e métodos de utilizacao destes | |
EA201101117A1 (ru) | Ингибиторы дпп-4 для лечения диабета у детей | |
CL2013001316A1 (es) | Composicion que comprende micro-organismo probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior. | |
BR112013013414A2 (pt) | dispositivos de coleta de sangue contendo agente de estabilização de sangue | |
BRPI1014919A2 (pt) | calçado impermeável e transpirante. | |
BRPI0915147A2 (pt) | retentor, mancal de esfera com sulco profundo e mancal com vedação | |
CL2009000299A1 (es) | Sistema optico y procedimiento para detectar la presencia de un elemento biologico vivo; sensor biometrico de identificador de personas. | |
CL2015000897A1 (es) | Composición farmacéutica que contiene un portador de oxígeno basado en hemoglobina para el tratamiento de focalización de cáncer y prevención de recurrencia de cáncer. | |
BRPI1009411A2 (pt) | preparação externa contendo um agente analgésico/antiinflamatório | |
BRPI0821720A2 (pt) | Aplicação de líquidos iônicos, magnéticos como agente de extração | |
FR2963357B1 (fr) | Materiau photoluminescent contenant de l'ion d'argent | |
CL2012003523A1 (es) | Método para la preparación de una composición farmacéutica que contiene un portador de oxígeno termoestable; composicion farmaceutica que contiene un portador de oxigeno altamente purificado y termoestable. | |
UY33455A (es) | Tableta con núcleo recubierto de liberación controlada | |
AR086395A1 (es) | Envase para el tratamiento de patologias | |
CL2014003055A1 (es) | Procedimiento para preparar una composicion farmaceutica que comprende i) proporcionar una primera combinacion que comprende un compuesto inhibidor del proteasoma peptidico, una o mas ciclodextrinas y agua, y ii) poner en contacto la primera combinacion con un acido para formar una segunda combinacion; composicion farmaceutica. | |
EA201390090A1 (ru) | Дезинфицирующий и антисептический препарат, имеющий сниженное содержание йода | |
BR112012019626A2 (pt) | estrutura de plantio e métodos. | |
BRPI0922246A2 (pt) | copolímero contendo blocos de construção ácida e vários tipos de blocos de construção de poliéter. | |
EA201270581A1 (ru) | Фармацевтические композиции севеламера | |
BR112013010709A2 (pt) | derivado de ácido trans-2-decenoico e agente farmacêutico contendo o mesmo | |
IT1401736B1 (it) | Dispositivo di perforazione per l'esecuzione di diaframmi e relativo metodo. | |
IT1401350B1 (it) | Veicolo - ambulanza per il trasporto di pazienti, feriti e simili | |
IT1402427B1 (it) | Metodo automatico di misura ed elaborazione della pressione sanguigna. | |
SMT201300027B (it) | Impianto e procedimento per la procuzione di una soluzione attivata elettrochimicamente |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20200807 |